News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Pfizer Inc. (PFE) CFO Reveals Money Killed AstraZeneca PLC (AZN) Deal


6/12/2014 5:31:45 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Pfizer Inc. (PFE) Chief Financial Officer Frank D’Amelio said the company’s $117 billion bid for AstraZeneca Plc (AZN) broke down over price.

Pfizer, the largest U.S. drugmaker, set a ceiling for how much it would pay for London-based AstraZeneca and wasn’t willing to go over that limit, D’Amelio said today at an investment conference organized by Goldman Sachs Group Inc. While New York-based Pfizer can approach AstraZeneca again after a U.K. regulatory period ends in six months, D’Amelio said he couldn’t comment about whether it will do so.

Help employers find you! Check out all the jobs and post your resume.

Read at Bloomberg
Read at Reuters
Read at Telegraph


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES